Log in to save to my catalogue

Clinical and Molecular Characterization of Glioma Patients: miR-21 Expression as a Prognostic Biomar...

Clinical and Molecular Characterization of Glioma Patients: miR-21 Expression as a Prognostic Biomar...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3131626240

Clinical and Molecular Characterization of Glioma Patients: miR-21 Expression as a Prognostic Biomarker in Tissue and Serum

About this item

Full title

Clinical and Molecular Characterization of Glioma Patients: miR-21 Expression as a Prognostic Biomarker in Tissue and Serum

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

Journal title

bioRxiv, 2024-11

Language

English

Formats

Publication information

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

More information

Scope and Contents

Contents

Background: Glioma remains challenging due to high recurrence rates and resistance to treatment. Diagnosis and follow-up in resource-constrained regions often leads to significant patient attrition. Serum microRNA (miRNA) expression profiles, which have been shown to correlate with tissue expression profiles, are detectable in peripheral blood samp...

Alternative Titles

Full title

Clinical and Molecular Characterization of Glioma Patients: miR-21 Expression as a Prognostic Biomarker in Tissue and Serum

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_3131626240

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3131626240

Other Identifiers

E-ISSN

2692-8205

DOI

10.1101/2024.11.20.624501